Atlas Trials

Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration

Clinical trial NCT02127463 · UNKNOWN

Trial details

NCT number
NCT02127463
Sponsor
MacuCLEAR, Inc.
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Non-Exudative Age Related Macular Degeneration
Start date
2014-04-01
Primary completion
2016-04-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.